Drugs available for asthma treatment in the first decades of the 20th century
(sympathomimetic agents such as oral ephedrine, intravenous adrenaline, or inhaled …

Asthma is an inflammatory disease of the airways characterized by intermittent episodes of
wheezing, chest tightness, and cough. Many of the inflammatory pathways implicated in …

The severity of the coronavirus disease (COVID-19) is associated with various comorbidities.
However, no studies have yet demonstrated the potential risk of respiratory failure and …

Rationale: There is a need to minimize oral corticosteroid (OCS) use in patients with asthma
to prevent their costly and burdensome adverse effects. Current guidelines do not provide …

abstract Asthma is characterized by chronic airway inflammation, variable airway narrowing,
and sensory nerve irritation, which manifest as wheezing, dyspnea, chest tightness, and …

Short courses of systemic corticosteroids (SCS), both oral and injectable, are very effective
for the resolution of acute asthma symptoms, including exacerbations. However, the benefits …

Systemic corticosteroids (SCS) are a highly effective treatment for acute exacerbations and
long-term symptom control in asthma. Long-term SCS use is highly prevalent across all …

Despite access to diagnostic tests and effective therapies, asthma often remains
misdiagnosed and/or poorly controlled or uncontrolled. In this review, we address the key …

Introduction Oral corticosteroids (OCS) for asthma are associated with increased risks of
developing adverse outcomes (adverse outcomes); no previous study has focused …

Background Biologics have proven efficacy for patients with severe asthma but there is lack
of consensus on defining response. We systematically reviewed and appraised …